ArticleCancer causes & control : CCC2026
Barriers and facilitators to exercise engagement during lung cancer treatment: a scoping review.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 'You've Given Me My Voice'-Enhancing Engagement in Exercise Oncology Research: A Patient and Public Involvement Approach to Co‑Designing a Pre‑Radiotherapy Exercise Programme With People Living With Lung Cancer.Health expectations : an international journal of public participation in health care and health policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEvidence suggests that exercising through lung cancer (LC) treatment may improve outcomes by modulating the tumor microenvironment and reducing hypoxia. However, recruitment and adherence challenges persist, limiting research progress and real-world implementation. Therefore, this scoping review aimed to explore the barriers and facilitators that influence exercise participation among individuals with LC during cancer treatment.
methodsThis ScR followed the JBI ScR methodology and the PRISMA-ScR checklist, using the participants-concept-context framework to define inclusion and exclusion criteria. The data were analyzed via qualitative content analysis with the themes presented in a narrative summary supported by tables and figures.
resultsThe initial search yielded n = 24,242 results, of which twenty-five studies (n = 25) were included for data extraction. The analysis identified 31 barriers and 42 facilitators grouped into five themes: physiological status; intrapersonal factors; program design and delivery; practical, logistical, and interpersonal factors; and professional/clinical considerations. Fatigue was the most frequently cited barrier, followed by intense periods of other treatment side effects experienced throughout treatment cycles. Conversely, personalized exercise programs and peer support were the most cited facilitators. Only two studies reported fatigue and muscle soreness as adverse events.
conclusionPeople with LC face many barriers that make exercising during treatment challenging. However, this review presents a list of exercise facilitators that researchers and service providers could adopt to inform the development of patient-centered exercise programs that encourage engagement, potentially leading to improved cancer treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.